Entrada Therapeutics TRDA
NASDAQ TRDA
$5.38 -0.30 (-5.28%)
At close: Oct 2, 2026 · 4:00 PM EDT

Entrada Therapeutics (TRDA) Price to Earnings (2024 - 2025)

Updated

Entrada Therapeutics' (TRDA) Price to Earnings stood at 13.84 in Q1 2025, down 31.7% from 20.28 a year earlier but up 39.8% from the prior quarter.

Analysis

Entrada Therapeutics (TRDA) Price to Earnings (2024 - 2025) Analysis & Trends

For FY2024, Entrada Therapeutics' Price to Earnings came in at 9.90.

  • Quarterly Price to Earnings has ranged from 5.07 in Q2 2024 to 20.28 in Q1 2024 over the past five years.
  • Per Business Quant, the preceding three quarters came in at 9.90 (Q4 2024), 10.88 (Q3 2024) and 5.07 (Q2 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Entrada Therapeutics 221.16 Mn 221.16 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 13.84
Dec 31, 2024 9.90
Sep 30, 2024 10.88
Jun 30, 2024 5.07
Mar 31, 2024 20.28
API Access

Entrada Therapeutics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=TRDA&period=max&api_key=YOUR_API_KEY